SCHEMBL19009549

SCHEMBL19009549

c1ccc(-c2ccc(-c3cc(-c4ccc(-c5ccccc5)cc4)nc(-c4ccc(-c5ccccn5)cc4)c3)cc2)cc1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP19A1 P11511 1/20 0.55
DHODH Q02127 1/20 0.53
KDM4E B2RXH2 4/20 0.52
LMNA P02545 4/20 0.52
TP53 P04637 3/20 0.52
SMN1; SMN2 Q16637 3/20 0.52
CCR1 P32246 3/20 0.52
CCR5 P51681 3/20 0.52
CCR8 P51685 3/20 0.52
TDP1 Q9NUW8 2/20 0.52
MAPK1 P28482 2/20 0.52
L3MBTL1 Q9Y468 2/20 0.52
ALPL P05186 1/20 0.52
HSP90AA1 P07900 1/20 0.52
ALPI P09923 1/20 0.52
ALPG P10696 1/20 0.52
ALOX15 P16050 1/20 0.52
HTT P42858 1/20 0.52
RAB9A P51151 4/20 0.51
PKM P14618 2/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17945878 1.00 CYP19A1 (0.55) CYP19A1DHODHKDM4ELMNATP53
SCHEMBL17945872 1.00 CYP19A1 (0.55) CYP19A1DHODHKDM4ELMNATP53
SCHEMBL17367836 0.98 CYP19A1 (0.53) CYP19A1DHODHKDM4ELMNATP53
SCHEMBL17932367 0.98 CYP19A1 (0.53) CYP19A1DHODHKDM4ELMNATP53
SCHEMBL17343429 0.96 CYP19A1 (0.51) CYP19A1DHODHKDM4ELMNATP53
SCHEMBL18961086 0.96 CYP19A1 (0.51) CYP19A1DHODHKDM4ELMNATP53
SCHEMBL17945879 0.96 KDM4E (0.56) CYP19A1DHODHKDM4ELMNATP53
SCHEMBL12148388 0.94 CYP19A1 (0.53) CYP19A1DHODHKDM4ELMNATP53
SCHEMBL14489448 0.94 CCR1 (0.56) CYP19A1DHODHKDM4ELMNATP53
SCHEMBL19009559 0.93 KDM4E (0.50) CYP19A1DHODHKDM4ELMNATP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11329230-B2 Organic light-emitting device SAMSUNG DISPLAY CO., LTD. (KR) 2022-05-10 US disclosed
US-20170317294-A1 ORGANIC LIGHT-EMITTING DEVICE SAMSUNG DISPLAY CO., LTD. (KR) 2017-11-02 US disclosed
US-20170317294-A1 ORGANIC LIGHT-EMITTING DEVICE SAMSUNG DISPLAY CO., LTD. (KR) 2017-11-02 US disclosed
US-20170179402-A1 ORGANIC LIGHT-EMITTING DEVICE SAMSUNG DISPLAY CO., LTD. (KR) 2017-06-22 US disclosed
US-20170179402-A1 ORGANIC LIGHT-EMITTING DEVICE SAMSUNG DISPLAY CO., LTD. (KR) 2017-06-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11329230-B2 Organic light-emitting device EML4, SUN2, TRPA1 CYP19A1 1341/4885DHODH 1447/4885KDM4E 2540/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.